Eternity Healthcare Competitors

Eternity Healthcare (OTCMKTS:ETAH) and Olink Holding AB (publ) (NASDAQ:OLK) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Eternity Healthcare and Olink Holding AB (publ), as reported by MarketBeat.com.

Olink Holding AB (publ) has a consensus price target of $44.00, suggesting a potential upside of 12.94%. Given Olink Holding AB (publ)'s higher probable upside, analysts clearly believe Olink Holding AB (publ) is more favorable than Eternity Healthcare.

Profitability

This table compares Eternity Healthcare and Olink Holding AB (publ)'s net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Eternity Healthcare and Olink Holding AB (publ)'s gross revenue, earnings per share (EPS) and valuation.

Summary

Olink Holding AB (publ) beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Eternity Healthcare (OTCMKTS:ETAH) and Ortho Clinical Diagnostics (NASDAQ:OCDX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current ratings and target prices for Eternity Healthcare and Ortho Clinical Diagnostics, as reported by MarketBeat.com.

Ortho Clinical Diagnostics has a consensus target price of $24.2727, suggesting a potential upside of 20.40%. Given Ortho Clinical Diagnostics' higher probable upside, analysts clearly believe Ortho Clinical Diagnostics is more favorable than Eternity Healthcare.

Earnings & Valuation

This table compares Eternity Healthcare and Ortho Clinical Diagnostics' top-line revenue, earnings per share and valuation.

Profitability

This table compares Eternity Healthcare and Ortho Clinical Diagnostics' net margins, return on equity and return on assets.

Summary

Ortho Clinical Diagnostics beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Biodesix (NASDAQ:BDSX) and Eternity Healthcare (OTCMKTS:ETAH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Biodesix and Eternity Healthcare, as reported by MarketBeat.

Biodesix currently has a consensus target price of $26.00, suggesting a potential upside of 43.41%. Given Biodesix's higher possible upside, equities analysts clearly believe Biodesix is more favorable than Eternity Healthcare.

Profitability

This table compares Biodesix and Eternity Healthcare's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Biodesix and Eternity Healthcare's revenue, earnings per share (EPS) and valuation.

Summary

Biodesix beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Lucira Health (NASDAQ:LHDX) and Eternity Healthcare (OTCMKTS:ETAH) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.

Profitability

This table compares Lucira Health and Eternity Healthcare's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Lucira Health and Eternity Healthcare's top-line revenue, earnings per share and valuation.

Analyst Ratings

This is a summary of recent ratings for Lucira Health and Eternity Healthcare, as provided by MarketBeat.com.

Lucira Health presently has a consensus price target of $9.00, indicating a potential upside of 29.31%. Given Lucira Health's higher probable upside, research analysts clearly believe Lucira Health is more favorable than Eternity Healthcare.

Summary

Lucira Health beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Akumin (NASDAQ:AKU) and Eternity Healthcare (OTCMKTS:ETAH) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Insider and Institutional Ownership

30.4% of Akumin shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Akumin and Eternity Healthcare's gross revenue, earnings per share and valuation.

Profitability

This table compares Akumin and Eternity Healthcare's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent recommendations for Akumin and Eternity Healthcare, as reported by MarketBeat.com.

Summary

Akumin beats Eternity Healthcare on 2 of the 2 factors compared between the two stocks.

Eternity Healthcare (OTCMKTS:ETAH) and Inotiv (NASDAQ:NOTV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Profitability

This table compares Eternity Healthcare and Inotiv's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Eternity Healthcare and Inotiv's gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Eternity Healthcare and Inotiv, as reported by MarketBeat.